Endocrinology & Metabolic Research
Diabetes Mellitus Type 1
Type 1 Diabetes is a chronic autoimmune condition that affects millions worldwide, requiring lifelong insulin management and continuous monitoring. CenExel is committed to advancing innovative therapies and clinical research solutions to improve glucose control, reduce complications, and enhance quality of life for pediatric, adolescent, and adult patients living with Type 1 Diabetes.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Type 1 Diabetes Clinical Research
CenExel provides specialized clinical research support for Type 1 Diabetes studies through experienced investigators, advanced metabolic monitoring, and patient-focused trial management. Our dedicated endocrinology teams work closely with sponsors to accelerate innovative diabetes therapies from early-phase development through post-market studies.
Conditions Covered
Diabetes Conditions We Research
Our Type 1 Diabetes research programs support a wide range of metabolic and endocrine-related conditions and treatment innovations.
- Type 1 Diabetes Mellitus (T1D)
- Pediatric Type 1 Diabetes
- Insulin Resistance
- Hypoglycemia Management
- Continuous Glucose Monitoring (CGM)
- Diabetic Ketoacidosis (DKA)
- Autoimmune Endocrine Disorders
- Insulin Pump Therapy
Our Approach
Why Sponsors Choose CenExel for Diabetes Research
CenExel combines scientific expertise, metabolic research capabilities, and patient-centered recruitment strategies to support successful diabetes clinical trials.
01
Endocrinology Specialists
Experienced diabetes investigators and certified endocrinology research teams across multiple research sites.
02
Advanced Glucose Monitoring
Access to CGM technologies, insulin pump integration, and real-time metabolic monitoring tools.
03
Diverse Patient Recruitment
Broad access to pediatric and adult Type 1 Diabetes patient populations across the United States.
04
High Retention Rates
Strong patient engagement programs designed to improve adherence and trial completion.
Phase Coverage
Supported Diabetes Trial Phases
CenExel supports early and late-phase diabetes research from first-in-human metabolic studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our diabetes research infrastructure supports insulin therapy evaluations, wearable glucose technologies, biomarker analysis, and precision metabolic medicine studies.
Diabetes Task Force
CenExel supports comprehensive metabolic and endocrine clinical trials focused on Type 1 Diabetes, insulin therapies, glucose monitoring systems, and emerging diabetes technologies for pediatric and adult populations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
